Diet may control seizures in epilepsy patients

Image
IANS London
Last Updated : Jan 17 2014 | 6:17 PM IST

The old assumption that what you eat manifests itself in your deeds cannot be just elderly wisdom.

A study by scientists at McGill University in Canada and University of Zurich in Switzerland shows a direct link between metabolism in brain cells and their ability to signal information.

The study has pushed the debate towards ketogenic diet - a high-fat, adequate-protein, low-carbohydrate diet that was in use in the past to treat epilepsy.

Metabolism controls the processes that inhibit brain activity, such as that involved in convulsions, said the research.

"Inhibition in the brain is commonly targeted in clinical practice," said Derek Bowie, Canada Research Chair in receptor pharmacology at McGill University.

"For example, drugs that alleviate anxiety or control epilepsy work by strengthening brain inhibition. These pharmacological approaches can have their drawbacks, since patients often complain of unpleasant side effects," Bowie added.

The findings, published in the journal Nature Communications, may explain why the seizures of many epilepsy patients can be controlled by a specially-formulated diet.

The researchers are trying to understand why seizures in many epilepsy patients - especially young children - can be treated with a high-fat, low-carbohydrate diet, earlier known as ketogenic diet.

From 1920s until 1950s, the ketogenic diet was widely used to treat epilepsy patients.

With the introduction of anticonvulsant drugs in the 1950s, the dietary approach fell out of favour with doctors.

But because anticonvulsant drugs do not work for 20-30 percent patients, there has been a resurgence in use of the ketogenic diet.

The new findings uncover a link between how brain cells make energy and how the same cells signal information - processes that neuroscientists have often assumed to be distinct and separate.

"Since our study shows that brain cells have their own means to strengthen inhibition, our work points to potentially new ways in which to control a number of important neurological conditions including epilepsy," said Bowie.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 17 2014 | 6:10 PM IST

Next Story